Thursday, April 13, 2017

Continuing Progress with OnCore

I’ve been trying to keep you updated on the status of the new MedStar Health and Georgetown University collaboration of the clinical trial management system (CTMS), OnCore. OnCore will serve as a workflow manager and repository of all clinical research administrative and management activities.

Announced in February 2016, we have been hard at work with a kick-off meeting and immersion training in April 2016, followed by the launch of two pilots, in oncology and cardiology, in late 2016. Our goal was to fully test and vet the system before rolling it out to all areas of clinical research.

Since our pilot go-live, we have made lots of progress in 2017. End user training for all Oncology Regulatory Coordinators and Clinical Research Coordinators (CRCs) took place in January, followed by the data migration of all Oncology studies and subjects to OnCore in February. End user training for all non-oncology Regulatory Coordinators and CRCs at MHRI also took place in February and March.Several studies, including newly activited studies are now going 'live' using OnCore to help manage the trial.

With end user training and the oncology data migration complete, we still have lots of work to do. For example, we are manually entering all new non-oncology studies into OnCore, along with calendars and budgets for each. So far, 25 studies are live in OnCore with calendars and budgets (23 studies in oncology, 2 cardiology studies), and we plan to add all active studies to OnCore by the end of the 2017 fiscal year in June.
Training and support activities for OnCore users continue, with twice-weekly training webinars and daily support calls.
Many thanks to those who have participated launching OnCore! It's a long process and we couldn't have made it this far without your contributions.

Associates can find more information on StarPort, including documentation, training tools, and dates for training. If you have any questions, please contact Research@MedStar.net.

No comments:

Post a Comment